| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −100.0% | |
| Gross profit | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | 0.0 | +100.0% | |
| Research & development | 1.1 | 3.6 | 6.5 | 7.7 | 15.5 | 17.2 | 20.3 | +17.9% | |
| Selling, general & administrative | 0.8 | 1.0 | 1.6 | 1.6 | 2.2 | 2.2 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 1.9 | 4.6 | 8.0 | 9.3 | 17.6 | 19.4 | 22.7 | +16.5% | |
| Operating income | (1.9) | (4.6) | (8.0) | (9.3) | (17.6) | (19.4) | (21.9) | −12.4% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.2 | 0.4 | 0.2 | 0.1 | 0.2 | +108.1% | |
| Other income / expense | 0.0 | 0.0 | 0.2 | 0.4 | 0.2 | 0.1 | — | — | |
| Pre-tax income | (1.9) | (4.6) | (7.8) | (8.9) | (17.4) | (19.4) | (21.7) | −12.0% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.9) | (4.6) | (7.8) | (8.9) | (17.4) | (19.4) | (22.5) | −16.1% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (0.15) | (0.35) | (0.61) | (0.69) | (1.21) | (1.43) | (1.48) | −3.8% | |
| EPS, diluted (per share) | (0.15) | (0.35) | (0.61) | (0.69) | (1.21) | (1.43) | (1.48) | −3.8% | |
| EBITDA | (1.9) | (4.6) | (7.8) | (8.9) | (17.4) | (19.4) | (21.8) | −12.6% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Weighted average shares (shares) | 12,703,541 | 12,944,134 | 12,913,848 | 12,848,165 | 13,014,585 | 13,534,994 | — | — | |
| Weighted average diluted shares (shares) | 12,703,541 | 12,944,134 | 12,913,848 | 12,848,165 | 13,014,585 | 13,534,994 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
